Gland Pharma gets U.S. FDA nod for Sugammadex injection
The product registered U.S. sales of around $1.6 billion for the twelve months ending April 2026
· 7/29/2026, 2:58:32 PM· 2 min read
The product registered U.S. sales of around $1.6 billion for the twelve months ending April 2026
Read original story →Related stories
business
Team Bharat asks for E10 availability, E0 at reasonable rates amid E20 backlash
business
Cognizant sees Q2 revenue rise 4.5%, raises FY26 EPS outlook
business
Indian young billionaires’ club gets bigger amid ageing population
business